Back to Agenda
Drawing the Boundaries of Data Disclosure in Clinical Trials
Session Chair(s)
Marie Manley
Partner, Head of EU and UK Life Sciences (UK), Sidley Austin LLP, United Kingdom
Drawing the Boundaries of Data Disclosure in Clinical Trials
Learning Objective : - Discuss the main changes introduced by the Clinical Trials Regulation; - Explain the perceived impact of the EU portal and database on clinical trials in the EU; and - Evaluate the amendments in the Clinical Trials Regulation and in particular the impact on transparency
Speaker(s)
Marie Manley
Partner, Head of EU and UK Life Sciences (UK), Sidley Austin LLP, United Kingdom
Sini Eskola, MPHARM, MS, MSC
Head of International Regulatory Policy and Innovation, Takeda, Belgium
Further Issues and Priorities to Be Solved
Have an account?